オプションチェーンは、LSB Industriesの株式オプションの主要データを様々な行使価格と満期日で表示します。トレーダーはこの情報を使用して、潜在的な取引を分析し、LSB Industriesの市場センチメントを評価します。.

LSB Industries (NYSE:LXU) 株価情報, オプションチェーン

LSB Industries

LSB Industries Inc is engaged in the manufacturing and sale of chemical products in the United States. The company manufactures and sells chemical products for the agricultural and industrial sectors. Its products include ammonia, fertilizer grade ammonium nitrate (AN and HDAN), and urea ammonia nitrate (UAN) for agricultural applications; high purity and commercial grade ammonia, sulfuric acids, concentrated, blended, and regular nitric acid, mixed nitrating acids, carbon dioxide, and diesel exhaust fluid for industrial applications; and industrial grade AN (LDAN) and AN solutions for mining applications. Its products are sold through distributors and directly to end customers throughout the United States and other parts of North America.

LSB Industries Inc

LSB Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LXU#NYSE">LXU</a>) reported quarterly losses of $(0.02) per share which missed the analyst consensus estimate of $0.05 by 140 percent. This is a 125 percent decrease over earnings of $0.08 per share from the same period last year. The company reported quarterly sales of $143.43 million which beat the analyst consensus estimate of $133.66 million by 7.31 percent. This is a 3.78 percent increase over sales of $138.20 million the same period last year.

Earnings

Earnings Beats

Earnings Misses

News

LSB Industries Q1 GAAP EPS $(0.02) Misses $0.05 Estimate, Sales $143.43M Beat $133.66M Estimate

ACGL

AEYE

AMSF

APAM

ARCB

ARCC

ASTE

ASTL

ATRC

BBIO

BBVA

BGFV

BKNG

BRSP

CECO

CHCT

CLVT

CSGP

CVLT

DHIL

ENSG

ENVA

ESRT

ETWO

EXLS

FELE

FFIC

FIBK

FICO

FOUR

FRSH

FRST

FSLR

FYBR

HLMN

HOUS

HRZN

HSBC

HURN

ILPT

INCY

INTZ

JAKK

JBGS

JBLU

KNSA

LFUS

LGIH

Laboratory Corporation Of America Holdings

LOGI

LXFR

Earnings Scheduled For April 29, 2025

LSB Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LXU#NYSE">LXU</a>) will release its quarterly earnings report on Tuesday, 2025-04-29. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate LSB Industries to report an earnings per share (EPS) of $0.04.
Investors in LSB Industries are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
<h3>Historical Earnings Performance</h3>
The company's EPS missed by $0.04 in the last quarter, leading to a 4.03% drop in the share price on the following day.
Here's a look at LSB Industries's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.11</td>
<td>-0.07</td>
<td>0.11</td>
<td>0.05</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.07</td>
<td>-0.11</td>
<td>0.13</td>
<td>0.08</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-4.0%</td>
<td>-3.0%</td>
<td>3.0%</td>
<td>13.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1745874097_0.png" alt="eps graph" />
<h3>Tracking LSB Industries's Stock Performance</h3>
Shares of LSB Industries were trading at $5.65 as of April 25. Over the last 52-week period, shares are down 36.67%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. 
<h3>Analyst Insights on LSB Industries</h3>
For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on LSB Industries.
A total of 1 analyst ratings have been received for LSB Industries, with the consensus rating being Buy. The average one-year price target stands at $8.0, suggesting a potential 41.59% upside.
<h3>Understanding Analyst Ratings Among Peers</h3>
The below comparison of the analyst ratings and average 1-year price targets of Intrepid Potash, Aspen Aerogels and Koppers Hldgs, three prominent players in the industry, gives insights for their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Sell trajectory for Intrepid Potash, with an average 1-year price target of $20.0, suggesting a potential 253.98% upside.</li>
<li>Analysts currently favor an Buy trajectory for Aspen Aerogels, with an average 1-year price target of $16.8, suggesting a potential 197.35% upside.</li>
<li>Analysts currently favor an Outperform trajectory for Koppers Hldgs, with an average 1-year price target of $64.0, suggesting a potential 1032.74% upside.</li>
</ul>
<h3>Peer Analysis Summary</h3>
The peer analysis summary offers a detailed examination of key metrics for Intrepid Potash, Aspen Aerogels and Koppers Hldgs, providing valuable insights into their respective standings within the industry and their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>LSB Industries</td>
<td>Buy</td>
<td>1.73%</td>
<td>$6.05M</td>
<td>-1.85%</td>
</tr>
<tr>
<td>Intrepid Potash</td>
<td>Sell</td>
<td>-1.52%</td>
<td>$7.29M</td>
<td>-35.85%</td>
</tr>
<tr>
<td>Aspen Aerogels</td>
<td>Buy</td>
<td>46.15%</td>
<td>$47.13M</td>
<td>2.02%</td>
</tr>
<tr>
<td>Koppers Hldgs</td>
<td>Outperform</td>
<td>-7.05%</td>
<td>$83.60M</td>
<td>-2.00%</td>
</tr>
</tbody>
</table>

Key Takeaway:
LSB Industries ranks at the bottom for Revenue Growth and Gross Profit among its peers. It is at the top for Consensus rating and Return on Equity.
<h3>Unveiling the Story Behind LSB Industries</h3>
LSB Industries Inc is engaged in the manufacturing and sale of chemical products in the United States. The company manufactures and sells chemical products for the agricultural and industrial sectors. Its products include ammonia, fertilizer grade ammonium nitrate (AN and HDAN), and urea ammonia nitrate (UAN) for agricultural applications; high purity and commercial grade ammonia, sulfuric acids, concentrated, blended, and regular nitric acid, mixed nitrating acids, carbon dioxide, and diesel exhaust fluid for industrial applications; and industrial grade AN (LDAN) and AN solutions for mining applications. Its products are sold through distributors and directly to end customers throughout the United States and other parts of North America.
<h3>Unraveling the Financial Story of LSB Industries</h3>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Positive Revenue Trend: Examining LSB Industries's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 1.73% as of 31 December, 2024, showcasing a substantial increase in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Materials sector.
Net Margin: LSB Industries's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of -6.78%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): LSB Industries's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive -1.85% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): LSB Industries's ROA stands out, surpassing industry averages. With an impressive ROA of -0.77%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: With a high debt-to-equity ratio of 1.06, LSB Industries faces challenges in effectively managing its debt levels, indicating potential financial strain.
<a href="https://www.benzinga.com/quote/LXU/earnings">To track all earnings releases for LSB Industries visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

A Preview Of LSB Industries's Earnings

UBS analyst Joshua Spector maintains LSB Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LXU#NYSE">LXU</a>) with a Buy and lowers the price target from $11 to $8.

Price Target

Analyst Ratings

UBS Maintains Buy on LSB Industries, Lowers Price Target to $8

LSB Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LXU#NYSE">LXU</a>) reported quarterly earnings of $0.07 per share which missed the analyst consensus estimate of $0.08 by 12.5 percent. This is a 200 percent increase over losses of $(0.07) per share from the same period last year. The company reported quarterly sales of $134.91 million which beat the analyst consensus estimate of $117.64 million by 14.68 percent. This is a 1.73 percent increase over sales of $132.61 million the same period last year.

LSB Industries Q4 Adj EPS $0.07 Misses $0.08 Estimate, Sales $134.91M Beat $117.64M Estimate

AAOI

ABEV

ACAD

ACMR

ADTN

ALEC

AMBA

AMBC

ARDT

ARHS

ARIS

ARKO

ATEC

AVDX

AVNS

BATRA

BATRK

BBSI

BLMN

BXSL

BYND

CAPL

CDNA

CERT

CLDT

CLPT

COCO

COMM

CORT

Core Scientific, Inc. - Class A Common Stock

CORZ

CPRX

CRGY

CSAN

CTRI

DMRC

DOLE

DORM

EBAY

ECPG

EHTH

ENIC

ENOV

ERII

ESCA

ESTA

EVTC

FTAI

FWRD

GERN

GOGL

GSX Techedu Inc. American Depositary Shares

GOTU

GRBK

HCAT

HNST

IBTA

IMCR

Earnings Scheduled For February 26, 2025

U.S. stocks were mixed, with the Dow Jones index gaining over 200 points on Monday.
Shares of Intra-Cellular Therapies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITCI#NASDAQ">ITCI</a>) rose sharply during Monday's session after Johnson &amp; Johnson agreed to acquire the company for $132.00 per share in cash for a total equity value of <a href="https://www.benzinga.com/general/biotech/25/01/42948170/like-bristol-myers-squibb-and-abbvie-johnson-johnson-seeks-to-bolster-neuropsychiatric-portfolio-with-15-billion-deal">approximately $14.6 billion</a>.
With this agreement, Johnson &amp; Johnson adds Intra-Cellular Therapies' Caplyta (lumateperone), a once-daily oral therapy approved to treat adults with schizophrenia, as well as depressive episodes associated with bipolar I or II disorder (bipolar depression), as a monotherapy and adjunctive therapy with lithium or valproate.
Intra-Cellular Therapies shares jumped 34.6% to $127.62 on Monday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>Sage Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAGE#NASDAQ">SAGE</a>) shares jumped 35.5% to $7.52. On Friday, Sage Therapeutics confirmed that Biogen Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIIB#NASDAQ">BIIB</a>) submitted an unsolicited, nonbinding proposal to acquire all of the outstanding shares of Sage Therapeutics not already owned by Biogen for $7.22 per share.</li>
<li>Standard BioTools Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LAB#NYSE">LAB</a>) gained 24% to $2.0250 after the company announced preliminary fourth-quarter and FY24 financial results.</li>
<li>LSB Industries, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LXU#NYSE">LXU</a>) rose 21% to $9.00 after Piper Sandler upgraded the stock from Underweight to Overweight and raised its price target from $9 to $11.</li>
<li>agilon health, inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGL#NYSE">AGL</a>) gained 17% to $2.86.</li>
<li>SI-BONE, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIBN#NASDAQ">SIBN</a>) rose 14.1% to $15.66 after the company announced preliminary revenue for the fourth quarter and full year 2024.</li>
<li>Critical Metals Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRML#NASDAQ">CRML</a>) climbed 13.9% to $8.85.</li>
<li>Trump Media &amp; Technology Group Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DJT#NASDAQ">DJT</a>) rose 13% to $39.92.</li>
<li>Radiopharm Theranostics Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RADX#NASDAQ">RADX</a>) climbed 12.2% to $6.00.</li>
<li>Nu Skin Enterprises, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NUS#NYSE">NUS</a>) gained 11.4% to $6.93 as the company announced fourth-quarter preliminary revenue at high end of guidance.</li>
<li>Blueprint Medicines Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BPMC#NASDAQ">BPMC</a>) rose 10.4% to $96.43 after the company reported a year-over-year increase in FY24 AYVAKIT revenue results.</li>
<li>Radiopharm Theranostics Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RADX#NASDAQ">RADX</a>) gained 10.3% to $5.90. Radiopharm Theranostics announced it will execute a private placement and will raise $5 million in proceeds.</li>
<li>United States Steel Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/X#NYSE">X</a>) gained 8.5% to $37.15 amid a report that Cleveland-Cliffs will partner with Nucor to make a potential bid for the company.</li>
<li>Humana Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUM#NYSE">HUM</a>) gained 6.6% to $286.90.</li>
<li>CF Industries Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CF#NYSE">CF</a>) rose 6.3% to $94.35. Piper Sandler analyst Charles Neivert upgraded CF Industries Holdings from Underweight to Overweight and raised the price target from $79 to $105.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/25/01/42947348/tesla-to-rally-around-9-here-are-10-top-analyst-forecasts-for-monday">Tesla To Rally Around 9%? Here Are 10 Top Analyst Forecasts For Monday</a></li>
</ul>

Intraday Update

Markets

Movers

Trading Ideas

BIIB

BPMC

CRML

ITCI

RADX

SAGE

SIBN

Intra-Cellular Therapies, Standard BioTools, SI-BONE And Other Big Stocks Moving Higher On Monday

WIIM

LSB Industries shares are trading higher after Piper Sandler upgraded the stock from Underweight to Overweight and raised its price target from $9 to $11.

Piper Sandler analyst Charles Neivert upgrades LSB Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LXU#NYSE">LXU</a>) from Underweight to Overweight and raises the price target from $9 to $11.

Upgrades

Piper Sandler Upgrades LSB Industries to Overweight, Raises Price Target to $11

RBC Capital analyst Andrew Wong reiterates LSB Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LXU#NYSE">LXU</a>) with a Outperform and maintains $10 price target.

Reiteration

RBC Capital Reiterates Outperform on LSB Industries, Maintains $10 Price Target

LSB Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LXU#NYSE">LXU</a>) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimate of $(0.07) by 57.14 percent. The company reported quarterly sales of $109.217 million which beat the analyst consensus estimate of $95.860 million by 13.93 percent. This is a 4.44 percent decrease over sales of $114.287 million the same period last year.

LSB Industries Q3 2024 Adj. EPS $(0.11) Misses $(0.07) Estimate, Sales $109.217M Beat $95.860M Estimate

LSB Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LXU#NYSE">LXU</a>) is set to give its latest quarterly earnings report on Tuesday, 2024-10-29. Here's what investors need to know before the announcement.
Analysts estimate that LSB Industries will report an earnings per share (EPS) of $-0.06. 
LSB Industries bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Overview of Past Earnings</h3>
The company's EPS beat by $0.02 in the last quarter, leading to a 2.74% increase in the share price on the following day.
Here's a look at LSB Industries's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.11</td>
<td>0.05</td>
<td>0.04</td>
<td>-0.12</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.13</td>
<td>0.08</td>
<td>-0.07</td>
<td>-0.10</td>
</tr>
<tr>
<td>Price Change %</td>
<td>3.0%</td>
<td>13.0%</td>
<td>2.0%</td>
<td>-2.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1730145746_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of LSB Industries were trading at $8.66 as of October 25. Over the last 52-week period, shares are down 3.9%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release. 
<h3>Analysts' Take on LSB Industries</h3>
Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on LSB Industries.
With 3 analyst ratings, LSB Industries has a consensus rating of Buy. The average one-year price target is $10.0, indicating a potential 15.47% upside.
<h3>Comparing Ratings with Peers</h3>
The below comparison of the analyst ratings and average 1-year price targets of Koppers Hldgs, Rayonier Adv Materials and Ecovyst, three prominent players in the industry, gives insights for their relative performance expectations and market positioning.
<ul>
<li>The consensus among analysts is an Outperform trajectory for Koppers Hldgs, with an average 1-year price target of $64.0, indicating a potential 639.03% upside.</li>
<li>Rayonier Adv Materials is maintaining an Outperform status according to analysts, with an average 1-year price target of $9.5, indicating a potential 9.7% upside.</li>
<li>For Ecovyst, analysts project an Buy trajectory, with an average 1-year price target of $11.0, indicating a potential 27.02% upside.</li>
</ul>
<h3>Overview of Peer Analysis</h3>
The peer analysis summary presents essential metrics for Koppers Hldgs, Rayonier Adv Materials and Ecovyst, unveiling their respective standings within the industry and providing valuable insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>LSB Industries</td>
<td>Buy</td>
<td>-15.54%</td>
<td>$27.41M</td>
<td>1.84%</td>
</tr>
<tr>
<td>Koppers Hldgs</td>
<td>Outperform</td>
<td>-2.43%</td>
<td>$121.60M</td>
<td>5.28%</td>
</tr>
<tr>
<td>Rayonier Adv Materials</td>
<td>Outperform</td>
<td>8.73%</td>
<td>$48.31M</td>
<td>1.52%</td>
</tr>
<tr>
<td>Ecovyst</td>
<td>Buy</td>
<td>-0.70%</td>
<td>$53.66M</td>
<td>1.16%</td>
</tr>
</tbody>
</table>

Key Takeaway:
LSB Industries ranks at the bottom for Revenue Growth among its peers. It is also at the bottom for Gross Profit. However, it is in the middle for Return on Equity.
<h3>Discovering LSB Industries: A Closer Look</h3>
LSB Industries Inc is engaged in the manufacturing and sale of chemical products in the United States. The company manufactures and sells chemical products for the agricultural, industrial, and mining markets. Its products include ammonia, fertilizer grade ammonium nitrate (AN and HDAN), and urea ammonia nitrate (UAN) for agricultural applications; high purity and commercial grade ammonia, sulfuric acids, concentrated, blended, and regular nitric acid, mixed nitrating acids, carbon dioxide, and diesel exhaust fluid for industrial applications; and industrial grade AN (LDAN) and AN solutions for mining applications. Its products are sold through distributors and directly to end customers throughout the United States and other parts of North America.
<h3>LSB Industries's Financial Performance</h3>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Decline in Revenue: Over the 3 months period, LSB Industries faced challenges, resulting in a decline of approximately -15.54% in revenue growth as of 30 June, 2024. This signifies a reduction in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Materials sector.
Net Margin: LSB Industries's net margin excels beyond industry benchmarks, reaching 6.82%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): LSB Industries's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 1.84% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): LSB Industries's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 0.78%, the company showcases efficient use of assets and strong financial health.
Debt Management: LSB Industries's debt-to-equity ratio is notably higher than the industry average. With a ratio of 0.97, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
<a href="https://www.benzinga.com/quote/LXU/earnings">To track all earnings releases for LSB Industries visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

A Look Ahead: LSB Industries's Earnings Forecast

U.S. stocks traded lower toward the end of trading, with the S&amp;P 500 falling around 0.3% on Thursday.
The Dow traded down 0.36% to 42,360.40 while the NASDAQ fell 0.20% to 18,255.32. The S&amp;P 500 also fell, dropping, 0.33% to 5,772.71.
Check This Out: <a href="https://www.benzinga.com/news/24/10/41270583/netflix-to-rally-around-13-here-are-10-top-analyst-forecasts-for-thursday">Netflix To Rally Around 13%? Here Are 10 Top Analyst Forecasts For Thursday</a>
Leading and Lagging Sectors Energy shares jumped by 1.1% on Thursday.
In trading on Thursday, real estate shares fell by 0.9%.
Top Headline
Domino's Pizza Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DPZ#NYSE">DPZ</a>) reported mixed third-quarter results on Thursday.
The company reported sales growth of 5.1% Y/Y to $1.08 billion, missing the analyst consensus estimate of $1.10 billion. EPS of $4.19 beat the consensus estimate of $3.68.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>BloomZ Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLMZ#NASDAQ">BLMZ</a>) shares shot up 65% to $1.1801 after the company announced it was selected as the primary animation contractor for an upcoming project.</li>
<li>Shares of LSB Industries, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LXU#NYSE">LXU</a>) got a boost, surging 15% to $9.57. UBS analyst Joshua Spector upgraded LSB Industries from Neutral to Buy and raised the price target from $9.5 to $11.</li>
<li>Symbotic Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYM#NASDAQ">SYM</a>) shares were also up, gaining 16% to $27.05. Symbotic announced an agreement to implement multiple industry-leading warehouse automation systems for Walmex and strategic international expansion in Mexico.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Gritstone bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRTS#NASDAQ">GRTS</a>) shares dropped 61% to $0.0780 after the company announced it voluntarily filed for Chapter 11 restructuring.</li>
<li>Shares of Indivior PLC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INDV#NASDAQ">INDV</a>) were down 19% to $583.00 after the company reported preliminary third-quarter revenue guidance and cut its FY24 net revenue guidance below estimates.</li>
<li>10x Genomics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXG#NASDAQ">TXG</a>) was down, falling 24% to $15.76 after the company guided third-quarter preliminary revenue of $151.7 million, down 1% year over year.</li>
</ul>
Commodities In commodity news, oil traded up 4% to $76.13 while gold traded up 0.6% at $2,641.00.
Silver traded up 2% to $31.275 on Thursday, while copper rose 1% to $4.4445.
Euro zone
European shares closed lower today. The eurozone's STOXX 600 slipped 0.18%, Germany's DAX slipped 0.23% and France's CAC 40 fell 0.24%. Spain's IBEX 35 Index fell 0.72%, while London's FTSE 100 fell 0.07%.
Retail sales in Germany rose 1.6% month-over-month in August compared to a 1.5% gain in July.
Asia Pacific Markets
Asian markets closed higher on Thursday, with Japan's Nikkei 225 gaining 0.26%, Hong Kong's Hang Seng Index jumping 2.98%, China's Shanghai Composite Index gaining 1.32% and India's BSE Sensex rising 0.18%.
Producer prices in Japan rose by 2.8% year-over-year in September compared to a 2.6% increase in the prior month.
Economics
<ul>
<li>U.S. initial jobless claims rose by 33,000 from the prior week to 258,000 in the week ending October 5th, compared to market estimates of 230,000.</li>
<li>The annual inflation rate in the U.S. eased for a sixth straight month to 2.4% in September from 2.5% in the previous month, but came in above market estimates of 2.3%.</li>
<li>U.S. natural-gas stocks rose 82 billion cubic feet in the week ended Oct. 4, compared to a 55 billion cubic feet gain in the prior week.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/10/41270853/jim-cramer-likes-reddit-very-much-calls-accenture-a-great-buy"> </a>
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/10/41270853/jim-cramer-likes-reddit-very-much-calls-accenture-a-great-buy">Jim Cramer Likes Reddit Very Much, Calls Accenture A &#8216;Great Buy&#8217;</a></li>
</ul>
<a href="https://www.benzinga.com/trading-ideas/long-ideas/24/10/41270853/jim-cramer-likes-reddit-very-much-calls-accenture-a-great-buy">&nbsp;</a>

Equities

Eurozone

Commodities

BLMZ

GRTS

INDV

S&P Moves Lower; Domino's Pizza Posts Mixed Q3 Results

U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining around 0.1% on Thursday.
The Dow traded down 0.17% to 42,437.66 while the NASDAQ rose 0.12% to 18,313.25. The S&amp;P 500 also fell, dropping, 0.05% to 5,789.32.
Check This Out: <a href="https://www.benzinga.com/news/24/10/41270583/netflix-to-rally-around-13-here-are-10-top-analyst-forecasts-for-thursday">Netflix To Rally Around 13%? Here Are 10 Top Analyst Forecasts For Thursday</a>
Leading and Lagging Sectors Energy shares jumped by 0.6% on Thursday.
In trading on Thursday, industrials shares fell by 0.5%.
Top Headline
Delta Air Lines, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAL#NYSE">DAL</a>) reported downbeat third-quarter earnings on Thursday.
Delta reported third-quarter operating revenue growth of 1% year-over-year to $15.677 billion, beating the consensus of $14.674 billion. Adjusted operating revenue was $14.594 billion (almost flat YoY). Adjusted EPS was $1.50 (-26% YoY), missing the consensus of $1.52.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>BloomZ Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLMZ#NASDAQ">BLMZ</a>) shares shot up 73% to $1.2350 after the company announced it was selected as the primary animation contractor for an upcoming project.</li>
<li>Shares of LSB Industries, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LXU#NYSE">LXU</a>) got a boost, surging 12% to $9.31. UBS analyst Joshua Spector upgraded LSB Industries from Neutral to Buy and raised the price target from $9.5 to $11.</li>
<li>Symbotic Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYM#NASDAQ">SYM</a>) shares were also up, gaining 12% to $26.10. Symbotic announced an agreement to implement multiple industry-leading warehouse automation systems for Walmex and strategic international expansion in Mexico.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Gritstone bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRTS#NASDAQ">GRTS</a>) shares dropped 64% to $0.0707 after the company announced it voluntarily filed for Chapter 11 restructuring.</li>
<li>Shares of Indivior PLC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INDV#NASDAQ">INDV</a>) were down 19% to $7.66 after the company reported preliminary third-quarter revenue guidance and cut its FY24 net revenue guidance below estimates.</li>
<li>10x Genomics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXG#NASDAQ">TXG</a>) was down, falling 29% to $14.87 after the company guided third-quarter preliminary revenue of $151.7 million, down 1% year over year.</li>
</ul>
Commodities In commodity news, oil traded up 3.1% to $75.48 while gold traded up 0.7% at $2,644.80.
Silver traded up 1.7% to $31.175 on Thursday, while copper rose 0.5% to $4.4230.
Euro zone
European shares were lower today. The eurozone's STOXX 600 slipped 0.36%, Germany's DAX slipped 0.47% and France's CAC 40 fell 0.48%. Spain's IBEX 35 Index fell 0.76%, while London's FTSE 100 fell 0.08%.
Retail sales in Germany rose 1.6% month-over-month in August compared to a 1.5% gain in July.
Asia Pacific Markets
Asian markets closed higher on Thursday, with Japan's Nikkei 225 gaining 0.26%, Hong Kong's Hang Seng Index jumping 2.98%, China's Shanghai Composite Index gaining 1.32% and India's BSE Sensex rising 0.18%.
Producer prices in Japan rose by 2.8% year-over-year in September compared to a 2.6% increase in the prior month.
Economics
<ul>
<li>U.S. initial jobless claims rose by 33,000 from the prior week to 258,000 in the week ending October 5th, compared to market estimates of 230,000.</li>
<li>The annual inflation rate in the U.S. eased for a sixth straight month to 2.4% in September from 2.5% in the previous month, but came in above market estimates of 2.3%.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/10/41270853/jim-cramer-likes-reddit-very-much-calls-accenture-a-great-buy">&nbsp;</a>
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/10/41270853/jim-cramer-likes-reddit-very-much-calls-accenture-a-great-buy">Jim Cramer Likes Reddit Very Much, Calls Accenture A &#8216;Great Buy&#8217;</a></li>
</ul>
<a href="https://www.benzinga.com/trading-ideas/long-ideas/24/10/41270853/jim-cramer-likes-reddit-very-much-calls-accenture-a-great-buy">&nbsp;</a>

Crude Oil Surges 3%; Delta Air Lines Posts Downbeat Earnings

LSB Industries shares are trading higher after UBS upgraded the stock from Neutral to Buy and raised its price target from $9.5 to $11.

U.S. stocks were lower, with the Dow Jones index falling around 100 points on Thursday.
Shares of LSB Industries, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LXU#NYSE">LXU</a>) rose sharply during <a href="https://www.benzinga.com/quote/LXU/analyst-ratings">Thursday's session</a>.
UBS analyst Joshua Spector upgraded LSB Industries from Neutral to Buy and raised the price target from $9.5 to $11.
LSB Industries shares jumped 11.8% to $9.34 on Thursday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>Standard Lithium Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLI#NYSE">SLI</a>) shares jumped 13.9% to $2.1750.</li>
<li>GXO Logistics, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GXO#NYSE">GXO</a>) gained 13% to $57.47. On Wednesday, Citigroup analyst Ariel Rosa initiated coverage on GXO Logistics with a Buy rating and announced a price target of $60.</li>
<li>Trump Media &amp; Technology Group Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DJT#NASDAQ">DJT</a>) gained 9.2% to $22.46.</li>
<li>Universal Insurance Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UVE#NYSE">UVE</a>) rose 9% to $18.49.</li>
<li>Symbotic Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYM#NASDAQ">SYM</a>) gained 8% to $25.11. Symbotic announced an agreement to implement multiple industry-leading warehouse automation systems for Walmex and strategic international expansion in Mexico.</li>
<li>American Coastal Insurance Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACIC#NASDAQ">ACIC</a>) gained 7% to $10.03.</li>
<li>EVgo, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVGO#NASDAQ">EVGO</a>) climbed 6.6% to $7.53. EVgo entered into new MoU with longtime technology partner Delta Electronics to jointly develop next-generation EV charging architecture.</li>
<li>Celsius Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CELH#NASDAQ">CELH</a>) shares climbed 6.5% to $32.48.</li>
<li>IAMGOLD Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IAG#NYSE">IAG</a>) gained 5.3% to $4.7900.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41270889/this-nike-analyst-turns-bullish-here-are-top-5-upgrades-for-thursday">This Nike Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday</a></li>
</ul>

ACIC

CELH

EVGO

LSB Industries, Symbotic And Other Big Stocks Moving Higher On Thursday

UBS analyst Joshua Spector upgrades LSB Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LXU#NYSE">LXU</a>) from Neutral to Buy and raises the price target from $9.5 to $11.

UBS Upgrades LSB Industries to Buy, Raises Price Target to $11

Messer will invest $9 million in plant upgrades to LSB Industries' Cherokee, AL facility with the long-term CO2 purchase agreement extension
BRIDGEWATER, N.J., Sept. 9, 2024 /PRNewswire/ -- Messer, a leader in industrial gas innovations, is pleased to announce the long-term renewal of a CO2 purchase and sale agreement with LSB Industries, Inc., a leading producer of industrial and agricultural chemicals. Messer will subsequently commit more than $9 million into the liquid CO2 plant at LSB's Cherokee, AL facility to invest in the continued safe and reliable operations at the site.
"This partnership with LSB Industries bolsters our nationwide&nbsp;CO2 network providing supply chain continuity to our customers," said Chris Ebeling, Messer's Executive Vice President, Sales &amp; Marketing, North America. "The efficiency upgrades for the plant modernization effort will add more molecules to our network and reduce CO2 emissions at the site in-line with our sustainability goals."
&nbsp;
Messer, with its partner, LSB Industries, is proud to provide increased security of CO2&nbsp;supply to its customers in the decades to come.

Messer And LSB Industries Partner To Increase CO2 Reliability For Customers; Messer Will Invest $9M In Plant Upgrades To LSB Industries' Cherokee, AL Facility With The Long-Term CO2 Purchase Agreement Extension

Piper Sandler analyst Charles Neivert maintains LSB Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LXU#NYSE">LXU</a>) with a Underweight and raises the price target from $8.8 to $9.

Piper Sandler Maintains Underweight on LSB Industries, Raises Price Target to $9

Press Releases

LSB Industries, Inc. to Participate in Upcoming Investor Conferences

LSB Industries, Inc. Schedules 2024 Third Quarter Financial Results Release for Tuesday, October 29th and Conference Call for Wednesday, October 30th

LSB Industries, Inc. Reports Operating Results for the 2024 Third Quarter

LSB Industries, Inc. Appoints John Chandler as an Independent Member of the Board of Directors

LSB Industries Announces Publication of 2023 Sustainability Report

LSB Industries, Inc. Schedules 2024 Fourth Quarter and Full Year Financial Results Release for Wednesday, February 26th and Conference Call for Thursday, February 27th

LSB Industries, Inc. Reports Operating Results for the 2024 Fourth Quarter and Full Year and Provides Product Sales Volume Outlook for 2025

LSB Industries, Inc. Appoints Riccardo Bertocco as an Independent Member of the Board of Directors

LSB Industries, Inc. Schedules 2025 First Quarter Results Release for Tuesday, April 29th and Conference Call for Wednesday, April 30th

LSB Industries, Inc. Reports Operating Results for the 2025 First Quarter

CNNX

MTRX

USAC

AdvanSix

ASP Isotopes

Aspen Aerogels

American Vanguard Corporation Common Stock ($0.10 Par Value)

American Vanguard

Bioceres Crop Solutions Corp. - Ordinary Shares

Bioceres Crop Solutions

Core Molding Technologies Inc Common Stock

Core Molding Technologies

Ginkgo Bioworks Holdings, Inc. Class A Common Stock

Ginkgo Bioworks Holdings

Comments

LSB Industries

LSB Industries (LXU) オプション

LSB Industries (NYSE:LXU) 株価情報, オプションチェーン

ニュース

パートナーシップ

ベンジンガ・グローバル